Webinars

Home
ADVAC
Apply to ADVAC
Contact
Login

Home
ADVAC
Webinars

ADVAC

About us
Course
Scientific Committee
Sponsors
Webinars
Faculty 2025
Feature lectures

Updates on Dengue outbreaks and vaccines

Updates on Dengue outbreaks and vaccines

Meeting of : Tuesday 30 April 2024.

Presentations : - Dengue epidemiology: João Bosco Siqueira Junior , Instituto de Patologia Tropical e SaudePublica, Brazil - Dengue vaccines, GabrielaPaz-Bailey , National Center for Emerging and Zoonotic Infectious Diseases, US-CDC, PuertoRico

Bringing an Economic Lens to Vaccine Programs

Bringing an Economic Lens to Vaccine Programs

Meeting of : Wednesday 20 September 2023.

Presentations : - The Top 5 Things to Know About the Economics of Vaccines, David Bishai, Professor & Director, School of Public Health, University of Hong Kong (20 minutes) - Sustainability of Immunization Programs, Logan Brenzel , Consultant BMGF (20 minutes)

Overcoming the challenges to measles and rubella elimination in south-east asia

Overcoming the challenges to measles and rubella elimination in south-east asia

Meeting of : Wednesday 12 April 2023.

Presentations : Prof T. Jacob John , Co-Chair of India Expert Advisory Group on Measles and Rubella Elimination. Dr. Firdausi Qadri , Senior Scientist and Head, Mucosal Immunology and Vaccinology Unit Senior Director, Infectious Diseases Division, icddr,b, and Founder & Lead,...

One health: does it work? The example of Monkeypox

One health: does it work? The example of Monkeypox

Meeting of : Tuesday 6 December 2022.

Presentations : Introduction by Joris Vandeputte . Update on the animal monkeypox: Yoshi Nakazawa , US Centers for Disease Control and Prevention. Update on the human monkeypox: Brett W. Petersen , US Centers for Disease Control and Prevention.

The power and limitations of immunobridging studies: the example of COVID-19 vaccines

The power and limitations of immunobridging studies: the example of COVID-19 vaccines

Meeting of : Tuesday 13 September 2022.

Presentations : Bridging studies – why and how? Peter Dull , Bill & Melinda Gates Foundation. Criteria and requirement for the licensing of new vaccines with special emphasis on COVID-19 the view of EMA. Marco Cavaleri , Head of Office Biological Health Threats and Vaccine...

HPV vaccination: Prospect of moving to a one and only dose schedule

HPV vaccination: Prospect of moving to a one and only dose schedule

Meeting of : Tuesday 19 April 2022.

HPV Vaccination: The evidence in favour of a one and only dose schedule and its limitations. Presenter: Margaret Stanley, University of Cambridge, UK

PREVIOUS
NEXT

© 2024 ADVAC - Created by www.i-media.ch

Privacy Policy | Cookies